Neurological Surgery 脳神経外科52巻6号

2024年11月発行

特集 脳神経外科医が知っておくべき生活習慣病の最新治療

Ⅰ 総論

認知症と生活習慣病の関係

著者： 嶋﨑亮介¹ 栗原正典¹ 岩田淳¹

所属機関： ¹東京都健康長寿医療センター脳神経内科

ページ範囲：P.1113 - P.1122

文献概要

Point
・生活習慣病は認知症の発症に関与しており，特に中年期からの予防やコントロールが重要である．
・一部の降圧薬（ジヒドロピリジン系カルシウムチャネルブロッカー，アンジオテンシンⅡ受容体拮抗薬など）や，血糖降下薬（グルカゴン様ペプチド-1受容体作動薬，ナトリウム/グルコース共輸送体2阻害薬など），スタチンは認知症の発症を抑制する可能性がある．
・社会全体として早期から認知症の発症抑制も意識した生活習慣病の管理を行うことが重要である．

参考文献

1）Long S, et al：World Alzheimer report 2023：reducing dementia risk：never too early, never too late. Alzheimer's Disease International, London, 2023

2）二宮利治，他：認知症及び軽度認知障害の有病率調査並びに将来推計に関する研究　報告書．令和5年度老人保健事業推進費等補助金（老人保健健康増進等事業）. 2024

3）Livingston G, et al：Dementia prevention, intervention, and care：2020 report of the Lancet Commission. Lancet 396：413-446, 2020

4）McGrath ER, et al：Blood pressure from mid- to late life and risk of incident dementia. Neurology 89：2447-2454, 2017

5）Ninomiya T, et al：Midlife and late-life blood pressure and dementia in Japanese elderly：the Hisayama study. Hypertension 58：22-28, 2011

6）Abell JG, et al：Association between systolic blood pressure and dementia in the Whitehall II cohort study：role of age, duration, and threshold used to define hypertension. Eur Heart J 39：3119-3125, 2018

7）Pase MP, et al：Association of Ideal Cardiovascular Health With Vascular Brain Injury and Incident Dementia. Stroke 47：1201-1206, 2016

8）Yamada M, et al：Association between dementia and midlife risk factors：the Radiation Effects Research Foundation Adult Health Study. J Am Geriatr Soc 51：410-414, 2003

9）Qiu C, et al：The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4：487-499, 2005

10）Jani B, et al：Ageing and vascular ageing. Postgrad Med J 82：357-362, 2006

11）Hughes D, et al：Association of blood pressure lowering with incident dementia or cognitive impairment：a systematic review and meta-analysis. JAMA 323：1934-1944, 2020

12）SPRINT MIND Investigators for the SPRINT Research Group；Williamson JD, et al：Effect of intensive vs standard blood pressure control on probable dementia：a randomized clinical trial. JAMA 321：553-561, 2019

13）Ding J, et al：Antihypertensive medications and risk for incident dementia and Alzheimer's disease：a meta-analysis of individual participant data from prospective cohort studies. Lancet Neurol 19：61-70, 2020

14）Tully PJ, et al：Diuretic antihypertensive drugs and incident dementia risk：a systematic review, meta-analysis and meta-regression of prospective studies. J Hypertens 34：1027-1035, 2016

15）Hussain S, et al：Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients：a meta-analysis of prospective studies. Neurosci Lett 671：120-127, 2018

16）Paris D, et al：Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier. Mol Med 17：149-162, 2011

17）Peters R, et al：Investigation of antihypertensive class, dementia, and cognitive decline：a meta-analysis. Neurology 94：e267-e281, 2020　doi:10.1212/WNL.0000000000008732

18）Li NC, et al：Use of angiotensin receptor blockers and risk of dementia in a predominantly male population：prospective cohort analysis. BMJ 340：b5465, 2010　doi:10.1136/bmj.b5465

19）Kehoe PG：The coming of age of the angiotensin hypothesis in Alzheimer's disease：progress toward disease prevention and treatment? J Alzheimers Dis 62：1443-1466, 2018

20）van Dalen JW, et al：Association of angiotensin II-stimulating antihypertensive use and dementia risk：post hoc analysis of the preDIVA trial. Neurology 96：e67-e80, 2021　doi:10.1212/WNL.0000000000010996

21）Chatterjee S, et al：Type 2 diabetes as a risk factor for dementia in women compared with men：a pooled analysis of 2.3 million people comprising more than 100, 000 cases of dementia. Diabetes Care 39：300-307, 2016

22）日本糖尿病学会（編）：糖尿病治療ガイド 2022-2023．文光堂，東京，2022

23）Song J, et al：HbA1c variability and the risk of dementia in patients with diabetes：a meta-analysis. Int J Clin Pract 2022：7706330, 2022　doi:10.1155/2022/7706330

24）Papachristoforou E, et al：Association of glycemic indices（hyperglycemia, glucose variability, and hypoglycemia）with oxidative stress and diabetic complications. J Diabetes Res 2020：7489795, 2020　doi:10.1155/2020/7489795

25）McMillan JM, et al：Impact of pharmacological treatment of diabetes mellitus on dementia risk：systematic review and meta-analysis. BMJ Open Diabetes Res Care 6：e000563, 2018　doi:10.1136/bmjdrc-2018-000563

26）Areosa Sastre A, et al：Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database Syst Rev 6：CD003804, 2017　doi:10.1002/14651858.CD003804.pub2

27）Tang X, et al：Impact of intensive glucose control on brain health：meta-analysis of cumulative data from 16, 584 patients with type 2 diabetes mellitus. Diabetes Ther 12：765-779, 2021

28）Ye F, et al：Impact of insulin sensitizers on the incidence of dementia：a meta-analysis. Dement Geriatr Cogn Disord 41：251-260, 2016

29）Qing-Qing Z, et al：Metformin therapy and cognitive dysfunction in patients with type 2 diabetes：a meta-analysis and systematic review. Medicine（Baltimore）99：e19378, 2020　doi:10.1097/MD.0000000000019378.

30）Tang H, et al：Newer glucose-lowering drugs and risk of dementia：a systematic review and meta-analysis of observational studies. J Am Geriatr Soc 71：2096-2106, 2023

31）Kuate Defo A, et al：Diabetes, antidiabetic medications and risk of dementia：A systematic umbrella review and meta-analysis. Diabetes Obes Metab 26：441-462, 2024

32）Jin Y, et al：The effects of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists on cognitive functions in adults with type 2 diabetes mellitus：a systematic review and meta-analysis. Acta Diabetol 57：1129-1144, 2020

33）Solomon A, et al：Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord 28：75-80, 2009

34）Mainous AG 3rd, et al：Cholesterol, transferrin saturation, and the development of dementia and Alzheimer's disease：results from an 18-year population-based cohort. Fam Med 37：36-42, 2005

35）Mielke MM, et al：High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology 64：1689-1695, 2005

36）Bennet AM, et al：Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298：1300-1311, 2007

37）Anstey KJ, et al：Updating the evidence on the association between serum cholesterol and risk of late-life dementia：review and meta-analysis. J Alzheimers Dis 56：215-228, 2017

38）Padala KP, et al：Simvastatin-induced decline in cognition. Ann Pharmacother 40：1880-1883, 2006

39）Olmastroni E, et al：Statin use and risk of dementia or Alzheimer's disease：a systematic review and meta-analysis of observational studies. Eur J Prev Cardiol 29：804-814, 2022

40）McGuinness B, et al：Statins for the prevention of dementia. Cochrane Database Syst Rev 2016：CD003160, 2016　doi:10.1002/14651858.CD003160.pub3

41）Ngandu T, et al：A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people（FINGER）：a randomised controlled trial. Lancet 385：2255-2263, 2015

42）Rosenberg A, et al：Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics：the FINGER trial. Alzheimers Dement 14：263-270, 2018

43）Sakurai T, et al：Japan-multimodal intervention trial for the prevention of dementia：a randomized controlled trial. Alzheimers Dement 20：3918-3930, 2024